Prelude Capital Management’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Prelude Capital Management’s Portfolio TGAN Stock Details TGAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-24,243	Closed	-$119K	–	1572
2024 Q1	$119K	Buy	+24,243	New	+$115K	0.01%	1184

Prelude Capital Management's TGAN Position: Q2 2024 in Review

Prelude Capital Management sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 24,243 shares — an estimated $119K sold.

Prelude Capital Management first reported a position in TGAN in Q1 2024 and held it in 1 quarter. The position peaked at $119K in Q1 2024. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

Prelude Capital Management reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Prelude Capital Management sold 24,243 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $119K.
Prelude Capital Management first reported a position in Transphorm, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Prelude Capital Management's Transphorm, Inc. Common Stock position peaked at $119K in Q1 2024.
0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on Prelude Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.